You appear to be offline. Some data may be unavailable until your connection is restored.
Description
Danaher Corporation is a diversified industrial and healthcare conglomerate that designs, manufactures, and markets scientific and medical instruments, consumables, software, and related services. It operates primarily through three segments—Biotechnology, Life Sciences, and Diagnostics—providing tools such as bioprocessing equipment, analytical instruments, clinical testing platforms, and the reagents needed to run them. The company’s business model combines high‑margin equipment sales with recurring revenue from consumables, maintenance contracts, and software, driven by its proprietary Danaher Business System of continuous improvement. Danaher is a leading supplier to pharmaceutical, biotechnology, academic, and clinical customers worldwide and is a prominent component of the S&P 500 health‑care sector.
Quarterly Earnings
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q2 FY26 | Jul 21, 2026 | — |
| Q1 FY26 | Apr 21, 2026 | $2.06 |
| Q4 FY25 | Jan 28, 2026 | $2.23 |
| Q3 FY25 | Oct 21, 2025 | $1.89 |
| Q2 FY25 | Jul 22, 2025 | $1.80 |
Stay ahead of DHR earnings
Get reminders ahead of DHR's next earnings report, so you always know when results are coming.